Clinical Trial Update: A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating whether the combination of finerenone and empagliflozin provides added safety and efficacy compared with each drug alone in adults wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Jardiance (empagliflozin)
• Kerendia (finerenone)

Snippet

Sponsor: Bayer | Conditions: Type 2 Diabetes Mellitus, Chronic Kidney Disease | Phase 2 | Status: COMPLETED